CASI Pharmaceuticals, Inc. financial data

Symbol
CASI on Nasdaq
Location
Beijing, China
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 31 Mar 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15,492,581 shares 16%
Common Stock, Shares, Outstanding 15,492,581 shares 16%
Common Stock, Value, Issued $2,000 USD 100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $13,468,000 USD -21%
Accounts Receivable, after Allowance for Credit Loss, Current $15,345,000 USD 61%
Inventory, Net $5,252,000 USD -67%
Assets, Current $39,576,000 USD -33%
Property, Plant and Equipment, Net $7,868,000 USD -15%
Operating Lease, Right-of-Use Asset $3,492,000 USD 46%
Intangible Assets, Net (Excluding Goodwill) $238,000 USD -87%
Other Assets, Noncurrent $587,000 USD -23%
Assets $53,674,000 USD -29%
Accounts Payable, Current $2,723,000 USD -39%
Liabilities, Current $36,452,000 USD 118%
Operating Lease, Liability, Noncurrent $2,535,000 USD 57%
Other Liabilities, Noncurrent $15,371,000 USD -0.72%
Liabilities $51,823,000 USD 1.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,774,000 USD -48%
Retained Earnings (Accumulated Deficit) $700,075,000 USD -5.9%
Stockholders' Equity Attributable to Parent $1,851,000 USD -92%
Liabilities and Equity $53,674,000 USD -29%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 15,904,533 shares 15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance $62,466,000 USD 1.9%
Operating Lease, Liability $3,756,000 USD 60%
Lessee, Operating Lease, Liability, to be Paid $4,029,000 USD 56%
Property, Plant and Equipment, Gross $13,575,000 USD -2.3%
Operating Lease, Liability, Current $1,221,000 USD 68%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,237,000 USD 145%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,343,000 USD 85%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $273,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $854,000 USD 120%
Deferred Tax Assets, Operating Loss Carryforwards $48,548,000 USD 14%
Unrecognized Tax Benefits $558,000 USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Four $340,000 USD -2.9%
Additional Paid in Capital $713,302,000 USD 2.5%
Deferred Tax Assets, Net of Valuation Allowance $937,000 USD 38%